Skip to main content

Carl R. Woese Institute for Genomic Biology

Where Science Meets Society

Cancer Drug Tested in Pet Dogs is Now Bound for Human Trials

Cancer Drug Tested in Pet Dogs is Now Bound for Human Trials

Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising anti-cancer effects in cell culture, in mouse models of cancer and in pet dogs with spontaneously occurring lymphomas and osteosarcomas.

Subscribe to Vanquish Oncology